The avoidance of G-CSF and the addition of prophylactic corticosteroids after autologous stem cell transplantation for multiple myeloma patients appeal for the at-home setting to reduce readmission for neutropenic fever
Open Access
- 4 November 2020
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (11) , e0241778
Abstract
Autologous stem cell transplantation (ASCT) remains the standard of care for young multiple myeloma (MM) patients; indeed, at-home ASCT has been positioned as an appropriate therapeutic strategy. However, despite the use of prophylactic antibiotics, neutropenic fever (NF) and hospital readmissions continue to pose as the most important limitations in the outpatient setting. It is possible that the febrile episodes may have a non-infectious etiology, and engraftment syndrome could play a more significant role. The aim of this study was to analyze the impact of both G-CSF withdrawal and the addition of primary prophylaxis with corticosteroids after ASCT. Between January 2002 and August 2018, 111 MM patients conditioned with melphalan were managed at-home beginning +1 day after ASCT. Three groups were established: Group A (n = 33) received standard G-CSF post-ASCT; group B (n = 32) avoided G-CSF post-ASCT; group C (n = 46) avoided G-CSF yet added corticosteroid prophylaxis post-ASCT. The incidence of NF among the groups was reduced (64%, 44%, and 24%; P2 (OR 6.1; P = 0.002) and G-CSF avoidance plus corticosteroids (OR 0.1; PP = 0.04) and G-CSF avoidance plus corticosteroids (OR 0.07; P = 0.05). G-CSF avoidance and corticosteroid prophylaxis post ASCT minimize the incidence of NF in MM patients undergoing at-home ASCT. This approach should be explored in a prospective randomized clinical trial.Keywords
This publication has 45 references indexed in Scilit:
- Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costsBone Marrow Transplantation, 2011
- The role of the endothelium in the short-term complications of hematopoietic SCTBone Marrow Transplantation, 2011
- Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2011
- Engraftment syndrome after auto-SCT: analysis of diagnostic criteria and risk factors in a large series from a single centerBone Marrow Transplantation, 2010
- Regression modeling of competing risk using R: an in depth guide for cliniciansBone Marrow Transplantation, 2010
- Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global PerspectiveTransplantation and Cellular Therapy, 2009
- Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndromeEuropean Journal of Haematology, 2008
- Case-Control Comparison of At-Home to Total Hospital Care for Autologous Stem-Cell Transplantation for Hematologic MalignanciesJournal of Clinical Oncology, 2006
- Prophylaxis of early bacterial infections after autologous peripheral blood stem cell transplantation (PBSCT): a matched-pair study comparing oral fluoroquinolones and intravenous piperacillin–tazobactamBone Marrow Transplantation, 2005
- Steroids prevent engraftment syndrome after autologous hematopoietic stem cell transplantation without increasing the risk of infectionBone Marrow Transplantation, 2005